Log in
Enquire now
Kivu Bioscience

Kivu Bioscience

Kivu Bioscience is pioneering next-generation antibody-drug conjugates (ADCs) in oncology.

OverviewStructured DataIssuesContributors

Contents

kivubioscience.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biotechnology
Biotechnology
Location
San Francisco, California, United
San Francisco, California, United
B2X
B2B
B2B
Number of Employees (Ranges)
1 – 10
Investors
Red Tree Venture Capital
Red Tree Venture Capital
Gimv
Gimv
HealthCap
HealthCap
M Ventures
M Ventures
BioGeneration Ventures
BioGeneration Ventures
Total Funding Amount (USD)
92,000,000
Latest Funding Round Date
October 28, 2024
Latest Funding Type
Series A
Series A
COO
‌
Mohit Trikha, PhD

Other attributes

Latest Funding Round Amount (USD)
92,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Kivu Bioscience

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Become an Editor
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.